Rational empiric antibiotic prescription in the ICU
- PMID: 10807841
- DOI: 10.1378/chest.117.5.1496
Rational empiric antibiotic prescription in the ICU
Abstract
The prescribing of antibiotics in the ICU is usually empiric, given the critical nature of the conditions of patients hospitalized there. Appropriate antibiotic utilization in this setting is crucial not only in ensuring an optimal outcome, but in curtailing the emergence of resistance and containing costs. We propose that research in the ICUs is vitally important in guiding antibiotic prescription practices and, therefore, the achievement of above-stated goals. There is wide institutional diversity in the relative prevalence of predominant pathogens and their antimicrobial susceptibilities, and within individual ICUs there exist unique patient populations with varying risks for and susceptibilities to infections and specific pathogens. Appropriate antibiotic prescription practices should be formulated based on surveillance studies and research at individual ICUs; these goals can be accomplished utilizing existing resources.
Similar articles
-
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3. Trials. 2017. PMID: 28114979 Free PMC article. Clinical Trial.
-
Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens.Chest. 1999 Mar;115(3 Suppl):34S-41S. doi: 10.1378/chest.115.suppl_1.34s. Chest. 1999. PMID: 10084458 Review.
-
Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.Intensive Care Med. 1996 May;22(5):387-94. doi: 10.1007/BF01712153. Intensive Care Med. 1996. PMID: 8796388
-
[The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jan;21(1):36-9. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009. PMID: 19141190 Chinese.
-
Treating serious infections: focus on cefepime.Pharmacotherapy. 2004 Dec;24(12 Pt 2):216S-23S. doi: 10.1592/phco.24.18.216S.52237. Pharmacotherapy. 2004. PMID: 15585451 Review.
Cited by
-
COVID-19 Lockdowns May Reduce Resistance Genes Diversity in the Human Microbiome and the Need for Antibiotics.Int J Mol Sci. 2021 Jun 26;22(13):6891. doi: 10.3390/ijms22136891. Int J Mol Sci. 2021. PMID: 34206965 Free PMC article.
-
The Role of Biomarkers and Scores in Describing Urosepsis.Medicina (Kaunas). 2023 Mar 17;59(3):597. doi: 10.3390/medicina59030597. Medicina (Kaunas). 2023. PMID: 36984597 Free PMC article.
-
Drug Therapy Problems and Predictors Among Patients Admitted to Medical Wards of Dilla University Referral Hospital, South Ethiopia: A Case of Antimicrobials.Infect Drug Resist. 2020 Jun 12;13:1743-1750. doi: 10.2147/IDR.S247587. eCollection 2020. Infect Drug Resist. 2020. PMID: 32606824 Free PMC article.
-
Transportability of bacterial infection prediction models for critically ill patients.J Am Med Inform Assoc. 2023 Dec 22;31(1):98-108. doi: 10.1093/jamia/ocad174. J Am Med Inform Assoc. 2023. PMID: 37647884 Free PMC article.
-
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical